Auvelity preliminary 4Q and full year 2024 net product sales of $92.6 million and $291.4 million, respectively
Sunosi preliminary 4Q and full year 2024 net product revenue of $25.7 million and $93.8 million, respectively
https://www.globenewswire.com/news-release/2025/01/13/3008327/33090/en/Axsome-Therapeutics-Provides-Preliminary-Fourth-Quarter-and-Full-Year-2024-Net-Revenue.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.